Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 103846
Company: ELAN PHARM
Company: ELAN PHARM
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| MYOBLOC | Botulinum Toxin Type B | 5000IU/VIAL | VIAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 12/08/2000 | ORIG-1 | Approval | N/A; Orphan |
Label (PDF)
Letter Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/botelan120800lb.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/botelan120800L.htm https://web.archive.org/web/20170201030814/https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm080661.htm |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 03/10/2021 | SUPPL-5195 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/103846Orig1s5195ltr.pdf | |
| 08/20/2019 | SUPPL-5190 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103846s5190lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/103846Orig1s5190ltr.pdf | |
| 06/13/2012 | SUPPL-5156 | Supplement |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/103846s5156ltr.pdf |
| 07/31/2009 | SUPPL-5120 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103846s5120lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/103846s5120ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 03/10/2021 | SUPPL-5195 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf | |
| 03/10/2021 | SUPPL-5195 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf | |
| 08/20/2019 | SUPPL-5190 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103846s5190lbl.pdf | |
| 08/20/2019 | SUPPL-5190 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103846s5190lbl.pdf | |
| 07/31/2009 | SUPPL-5120 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103846s5120lbl.pdf | |
| 12/08/2000 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/botelan120800lb.pdf |